SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

ABBV

AbbVie Inc.
NYSEHealth Care

Latest close: 285.42 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 15, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Oct 5, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Sep 3, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record1,2945 flagged findings
Reported transactions (Form 4)80since Feb 26, 2025 · and 29 other holdings
Corporate events (8-K)30since Nov 26, 2019

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

What the company does

AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.

Source: Wikipedia (CC BY-SA 4.0) · copied on Sep 3, 2026 · may not reflect recent changes.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-06-22merger or acquisition eventrecentOpen filing ↗
    “…benefits of the proposed acquisition of Apogee by AbbVie and the associated integration plans, anticipated future operating…”
    +1 more passage from the same document
    • “…and the associated integration plans, anticipated future operating performance and results of Apogee, the expected accretion to…”
  • 2026-05-08capital return (buybacks/dividends)recentOpen filing ↗
    “…. 2026 Form 10-Q | 15 Cash Dividends The following table summarizes quarterly cash dividends declared during 2026 and 2025: 2026…”
    +1 more passage from the same document
    • “…following table summarizes quarterly cash dividends declared during 2026 and 2025: 2026 2025 Date Declared Payment Date Dividend…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 1,294)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 15, 268-K ↗Current report · A senior executive left or was appointed new
  • Oct 5, 268-K ↗Current report · Results
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Sep 3, 268-K ↗Current report · Communication to the market
  • Aug 18, 26Form 4 ↗Insider transaction
  • Aug 18, 268-K ↗Current report · Other events
  • Aug 14, 26Form 144 ↗Notice of proposed sale
  • Aug 6, 26424B5 ↗Securities offering
  • Aug 5, 268-K ↗Current report · Other events
  • Aug 4, 26424B5 ↗Securities offering
  • Aug 3, 2610-Q ↗Quarterly report
  • Jul 31, 268-K ↗Current report · Results
  • Jul 6, 268-K ↗Current report · Results
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Jun 22, 268-K ↗Current report · Communication to the market
  • May 26, 26Form 144 ↗Notice of proposed sale
  • Insider transaction · 7 Form 4 filingsshow all 7hide

1,294 filings on record, the oldest from Dec 7, 12.

Listing the 25 most recent filings of the 1,294 on record.

8-Ks, explained

Stress2Structure55Governance31
  • Governance3 senior executive changes2025 – 2026show all 3hide
    • Oct 15, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • May 13, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Feb 14, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jan 10, 25StressWrite-down of assets8-K 2.06 ↗
  • Governance5 senior executive changes2023 – 2024show all 5hide
    • Dec 13, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • May 8, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K/A 5.02 ↗
    • Feb 20, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Oct 12, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jun 29, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Mar 28, 23StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Governance10 senior executive changes2020 – 2022show all 10hide
    • Nov 29, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Oct 17, 22GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Oct 14, 22GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jun 28, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Apr 13, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Mar 4, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Dec 17, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Dec 16, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jan 6, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Nov 12, 20GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • May 14, 20StructureCompleted an acquisition or disposal+1 more in the same filing8-K/A 2.01 ↗
  • May 14, 20StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • May 8, 20StructureCompleted an acquisition or disposal+5 more in the same filing8-K 2.01 ↗
  • Feb 14, 20StructureA material agreement was terminated8-K 1.02 ↗
  • Nov 26, 19StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗

The record reaches back to Dec 20, 12.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

The full record holds 2 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Aug 14, NICHOLAS DONOGHOE filed notice of intent to sell up to $8.2M.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $8.2M on Aug 14, per their Form 4. That is 100% of the shares announced so far, and the window is still open.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Aug 14, 26Sell$8.2MNicholas DonoghoeEVP, CHIEF BUS/STRAT OFFICER↗
  • Mar 4, 26Sell$1.2MDavid Ryan PurdueSVP, Controller↗
  • Mar 2, 26Sell$1.3MPerry C SiatisEVP, GC AND SECRETARY↗
  • Mar 2, 26Sell$2.4MPerry C SiatisEVP, GC AND SECRETARY↗
  • Mar 2, 26Sell$612KPerry C SiatisEVP, GC AND SECRETARY↗
  • Feb 25, 26Sell$5.1MPerry C SiatisEVP, GC AND SECRETARY↗
Stock compensation, tax and giftsshow the 34 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Aug 14, 26Compensation$2.6MNicholas DonoghoeEVP, CHIEF BUS/STRAT OFFICER↗
  • May 8, 26Compensationamount n/aROXANNE S AUSTIN↗
  • May 8, 26Compensationamount n/aEDWARD J RAPP↗
  • May 8, 26Compensationamount n/aTHOMAS J FALK↗
  • May 8, 26Compensationamount n/aFREDERICK H WADDELL↗
  • May 8, 26Compensationamount n/aTHOMAS C FREYMAN↗
  • May 8, 26Compensationamount n/aRebecca B Roberts↗
  • May 8, 26Compensationamount n/aBrett J Hart↗
  • May 8, 26Compensationamount n/aWILLIAM H.L. BURNSIDE↗
  • May 8, 26Compensationamount n/aMELODY B MEYER↗
  • May 8, 26Compensationamount n/aJennifer L. Davis↗
  • May 8, 26Compensationamount n/aSusan E Quaggin↗
  • Feb 27, 26Tax$3.8MAZITA SALEKI-GERHARDTEVP, CHIEF OPERATIONS OFFICER↗
  • Feb 27, 26Tax$8.5MRobert A. MichaelCHAIRMAN OF THE BOARD AND CEO↗
  • Feb 27, 26Tax$5.5MJeffrey Ryan StewartEVP, CHIEF COMMERCIAL OFFICER↗
  • Feb 27, 26Tax$3.0MNicholas DonoghoeEVP, CHIEF BUS/STRAT OFFICER↗
  • Feb 27, 26Tax$5.0MScott T ReentsEVP, CHIEF FINANCIAL OFFICER↗
  • Feb 27, 26Tax$3.4MPerry C SiatisEVP, GC AND SECRETARY↗
  • Feb 27, 26Tax$1.9MRoopal ThakkarEVP, R&D and CSO↗
  • Feb 27, 26Tax$370KDemetris D CrumEVP, CHIEF HR OFFICER↗
  • Feb 27, 26Tax$489KDavid Ryan PurdueSVP, Controller↗
  • Feb 25, 26Compensation$1.1MPerry C SiatisEVP, GC AND SECRETARY↗
  • Feb 25, 26Compensation$1.4MPerry C SiatisEVP, GC AND SECRETARY↗
  • Feb 25, 26Compensation$1.4MPerry C SiatisEVP, GC AND SECRETARY↗
  • Feb 18, 26Compensationamount n/aAZITA SALEKI-GERHARDTEVP, CHIEF OPERATIONS OFFICER↗
  • Feb 18, 26Compensationamount n/aAZITA SALEKI-GERHARDTEVP, CHIEF OPERATIONS OFFICER↗
  • Feb 18, 26Compensationamount n/aAZITA SALEKI-GERHARDTEVP, CHIEF OPERATIONS OFFICER↗
  • Feb 18, 26Compensationamount n/aAZITA SALEKI-GERHARDTEVP, CHIEF OPERATIONS OFFICER↗
  • Feb 18, 26Compensationamount n/aRobert A. MichaelCHIEF EXECUTIVE OFFICER↗
  • Feb 18, 26Compensationamount n/aRobert A. MichaelCHIEF EXECUTIVE OFFICER↗
  • Feb 18, 26Compensationamount n/aRobert A. MichaelCHIEF EXECUTIVE OFFICER↗
  • Feb 18, 26Compensationamount n/aRobert A. MichaelCHIEF EXECUTIVE OFFICER↗
  • Feb 18, 26Compensationamount n/aJeffrey Ryan StewartEVP, CHIEF COMMERCIAL OFFICER↗
  • Feb 18, 26Compensationamount n/aJeffrey Ryan StewartEVP, CHIEF COMMERCIAL OFFICER↗

The full record holds 387 transactions and goes back to Dec 31, 22.

Its sector and its market

AbbVie Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From AbbVie Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow AbbVie Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
1,294 documents on file, from Dec 7, 2012 to Oct 15, 2026.
Company description
Wikipedia, read on Sep 3, 2026.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.